Free Trial

Tyra Biosciences (TYRA) SEC Filings & 10K Form

Tyra Biosciences logo
$13.17 +0.39 (+3.05%)
Closing price 04:00 PM Eastern
Extended Trading
$13.18 +0.01 (+0.08%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tyra Biosciences SEC Filings

DateFilerForm TypeView
02/07/2025
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
4:42 PM
Canaan XI L.P. (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
3:41 PM
Canaan 2020+ Co-Investment L.P. Series 7 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
4:09 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:00 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
4:47 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:42 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
8:30 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
12/05/2024
3:21 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:06 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:47 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:31 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/14/2024
4:52 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:47 PM
NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:34 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/13/2024
5:04 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/08/2024
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:24 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
5:18 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:22 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
4:15 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
6:00 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:01 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:15 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
7:47 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
7:49 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:11 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
4:13 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:04 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:12 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
4:51 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
8:59 PM
Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/15/2024
6:22 PM
Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/02/2024
4:38 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
5:44 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
5:24 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:49 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:42 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:56 PM
Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Do this Before Elon’s Reveal on March 17th (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
09/18/2024
2:59 PM
Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM
Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:27 PM
Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
4:12 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:15 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:49 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:53 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:50 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:55 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:18 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:10 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
2:08 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
5:26 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Simson Jake (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:46 PM
Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:48 PM
Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:49 PM
Moran Susan (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:49 PM
Moran Susan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:08 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
11:15 PM
Tyra Biosciences (Filer)
Form EFFECT
04/05/2024
3:20 PM
Tyra Biosciences (Filer)
Form PRE 14A
03/19/2024
6:58 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:01 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:38 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:33 PM
Tyra Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2024
3:35 PM
Tyra Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2024
4:46 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
03/08/2024
4:38 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:40 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:58 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TYRA) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners